Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Elusive Link between 18FDG uptake and Glycolytic Flux explains the Preserved Diagnostic Accuracy of PET-CT in Diabetic Cancer Patients

Autor: V. Cossu 1, 2, M. Bauckneht 1, S. Bruno 3, A. Orengo 1, L. Emionite 4, F. Di Giulio 1, S. Capitanio 1, E. Balza 5, P. Castellani 5, P. Piccioli 5, A. Miceli 2, S. Raffa 2, A. Borra 2, M. Donegani 2, S. Morbelli 1, S. Ravera 3, G. Sambuceti 1, C. Marini 1, 6

Publikováno v: European journal of nuclear medicine and molecular imaging (Internet) 46 (2019): S697.
info:cnr-pdr/source/autori:V. Cossu 1,2, M. Bauckneht 1,2, S. Bruno 3, A. Orengo 1, L. Emionite 4, F. Di Giulio 1, S. Capitanio 1, E. Balza 5, P. Castellani 5, P. Piccioli 5, A. Miceli 2, S. Raffa 2, A. Borra 2, M. Donegani 2, S. Morbelli 1, S. Ravera 3, G. Sambuceti 1,2, C. Marini 1,6/titolo:The Elusive Link between 18FDG uptake and Glycolytic Flux explains the Preserved Diagnostic Accuracy of PET-CT in Diabetic Cancer Patients/doi:/rivista:European journal of nuclear medicine and molecular imaging (Internet)/anno:2019/pagina_da:S697/pagina_a:/intervallo_pagine:S697/volume:46

Aim/Introduction: The present study aims to verify whether the link between [18F]-2-deoxy-glucose (FDG) uptake and activity of the reticular enzyme hexose-6P-dehydrogenase (H6PD) contributes to preserve PET/CT diagnostic power in experimental models

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::ed23a7d14bbb2f4e15f69b42f6700ecb
http://www.cnr.it/prodotto/i/409536

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Measuring glucose consumption by dynamic FDG imaging to estimate cancer metabolism and evaluate treatment response to Sorafenib in a mouse model of intracranial gliobastoma: an Sorafenib in a mouse model of intracranial gliobastoma: an in Sorafenib in a mouse model of intracranial gliobastoma: an in vitro and in vivo study

Autor: M. Massollo, S. Capitanio, E. Carra, L. Emionite, F. Bongioanni, A. Democrito, S. Morbelli, E. Monteverde, Cecilia Marini, T. Florio, A. Daga, Gianmario Sambuceti.

Publikováno v: Clinical and Translational Imaging 1 (2013): S37–S38.
info:cnr-pdr/source/autori:M. Massollo; S. Capitanio; E. Carra; L. Emionite; F. Bongioanni; A. Democrito; S. Morbelli; E. Monteverde; Cecilia Marini;T. Florio; A. Daga; Gianmario Sambuceti./titolo:Measuring glucose consumption by dynamic FDG imaging to estimate cancer metabolism and evaluate treatment response to Sorafenib in a mouse model of intracranial gliobastoma: an Sorafenib in a mouse model of intracranial gliobastoma: an in Sorafenib in a mouse model of intracranial gliobastoma: an in vitro and in vivo study/doi:/rivista:Clinical and Translational Imaging/anno:2013/pagina_da:S37/pagina_a:S38/intervallo_pagine:S37–S38/volume:1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::3a3a2612cd1c78e071c7b5dfc4bff63c
https://publications.cnr.it/doc/206729